Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 345.00p 330.00p 360.00p 348.00p 345.00p 348.00p 0 08:11:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 19.6 233

Eco Animal Health Share Discussion Threads

Showing 951 to 975 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
31/8/2018
16:41
Another jump today. On the directors front, its a bit of a double edged sword. I believe they have done an excellent job with EAH and were not too greedy in the pre-authorisations days. Personally I have no problem with them reaping the rewards of their efforts. There are many shares for which I don't have this view.....EAH is a well run company.
audigger
28/8/2018
19:36
Yes, more selling of directors options. All the directors sell these and take as emoluments by the look of things. Be nice if one of the directors actually put their hand in their pocket and bought some shares at some point...seems to be an old fashioned concept these days. Far better to have your cake and eat it!
topvest
28/8/2018
17:54
And a bit of volume today....
audigger
28/8/2018
10:50
First news in a while, lets hope there's more to come!
audigger
28/8/2018
08:19
Another authorisation for Aivlosin this morning - for pigs and poultry in Vietnam.
aimingupward2
23/8/2018
19:06
Good to see this bounce back. Looks like Liontrust has taken the overhang by snapping up another 3%.
topvest
22/8/2018
09:51
Theses shares have fallen far too far and I am confident of a significant rise back to earlier levels.
aimingupward2
21/8/2018
19:32
Only 10ks worth. Bit lucky with timing really. I only bought today because I sold Syncona yesterday when it hit my target. That dropped a lot today so for once it appears I got lucky. Would be good to see another 20p on this tomorrow and some momentum north.
audigger
21/8/2018
18:51
Blimey, you must have bought a few! Nice to see this start to bounce. Weakness in the price seems to have been a delayed reaction to last year's EPS numbers that were disappointing due to mix of business last year and currency headwinds. FY19 is looking strong. Currency tailwind and hopefully a better mix.
topvest
21/8/2018
12:05
Sold another holding yesterday so added more of these today. Am thinking I will likely add again before it goes ex-divi. Having re-read the results i'm encouraged by their strategic intent to grow in to other product areas through both a combination of new product development (i.e. vaccines) and acquisition. Based on a solid platform of continued growth in Aivlosin sales and more registrations to come and huge barriers to entry for the competition, and an established and competent management team, I see no reason why the share price won't return to its previous high and beyond. The unknown is at what pace this goes. Things have been relatively quite in terms of new product authorisations so I'm hoping a steady stream of RNS is on the horizon.....!!!
audigger
20/8/2018
18:33
The authority is 11 months old so they have just 4 weeks to buy up to 650k. Not that significant. Arguably they have played a blinder as the share price was about £2 higher when they gained the authority. The simple statement that they have the authority but no certainty to use it hasn’t had any immediate effect. They might just have to actually use it then to arrest the current slide. I’m starting to think about topping up myself but not skilful enough to catch a falling knife.
steve3sandal
20/8/2018
17:40
Looks like they are contemplating a share buy-back. Some momentum traders have obviously exited, but I am sticking with this. Nothing has changed other than a weaker year of earnings. Nothing goes up in a straight line.
topvest
16/8/2018
20:28
Thought of EAH reading an FT article on the possible effects on the Chinese animal foods market with their increased input costs given the tariffs the Chinese have imposed on US soya imports. Pig production had been strong but there will be collateral damage of this increase in input costs. Too soon of course to know how much if at all it will impact EAH- and indeed ANP.
cerrito
09/8/2018
17:28
It could well fall further, but fairly confident it will bounce on FY19 numbers (interim and final) or further positive developments regulatory wise. There are not many better growth companies out there. Also, think there is quite a high chance of an acquisition, as from the final results there was a heavy steer that something was going on. No point carrying £20m of cash if you can invest it wisely. Time will tell, but they are not scaring me out of mine at this price. £6 it was probably close to a sell. Something starting with a 4 is not pricey for a growth company like this.
topvest
09/8/2018
17:22
In many respects this is a great buying opportunity but I'm not quite prepared to dive-in just yet. I tend not to be great with timing so it'll be up 50P tomorrow on good news!
audigger
09/8/2018
15:29
Should bounce back given we have high sales growth, dividend growing at 30% and exchange rate tailwind. 2017 was stellar, 2018 was a tad disappointing (due to currency headwind), 2019 should be stellar again (due to currency tailwind).
topvest
09/8/2018
15:29
Should bounce back given we have high sales growth, dividend growing at 30% and exchange rate tailwind. 2017 was stellar, 2018 was a tad disappointing (due to currency headwind), 2019 should be stellar again (due to currency tailwind).
topvest
09/8/2018
15:04
Someone dumped 50k at 450p, which moved the price.
jimbowen30
09/8/2018
14:51
We appear to be falling off a cliff!
audigger
09/8/2018
12:02
Share price is definitely in a bit of a downtrend, probably catching up with the poor EPS number in 2018. 2019 trade is strong and no doubt the recent weakness in sterling is now providing a headwind versus the 2018 tailwind. You would actually guess that the undershoot on 2018 will likely turn into an overshoot in 2019. I will remain patient. Think we will see well over 20p EPS this year, particularly if £ weakness continues.
topvest
06/8/2018
14:41
Did they not appoint a joint broker sometime ago that was a spcialist in take takeovers and mergers , at this level they must be looking very attractive.
winston8643
18/7/2018
12:04
Well,yes. It’s certainly very good value at this level and I feel very confident that we’ll see £7 by next summer - more if it were to become a takeover target.
aimingupward2
18/7/2018
11:40
Old mutual off-loading. Will we finally see the start of a recovery? Am pondering a top-up.
audigger
12/7/2018
21:37
Well I have to say that the recent share price movement is not what I expected. Topvest presents a very rational explanation as to the reasons why we are languishing, and its hard to disagree with the fundamentals. For me, things haven't quite progressed at the rate or scale I expected in the US. An excellent analysis of why this may be was posted by rzbrdbe on 28th Oct 17 (post 836). The management of this company has been excellent but I now wonder if PL and colleagues who have reaped significant rewards from the growth in the business and SP(and so they should) still have the same drive and enthusiasm to take this forward. I always believed EAH would be acquired by a bigger player but their strategy appeared to shift last year to one of growing organically and potentially through acquisition and thus become a big player themselves. They are cash rich so I guess this creates both opportunity and threat. The whole chemicals industry is still consolidating so again this will present EAH with opportunities but they are an attractive proposition themselves. My gut tells me that they are still more likely to be acquired than not. At what price? I have no idea as I'm not a number cruncher. My conclusion therefore is that I should be adding at this relatively low price. The downside has to be minimal aside from some bigger picture risks like antibiotic resistance and alternative technologies. So what's stopping me piling in? Only my preference for investing in earlier stage life science start-ups which are far riskier than EAH!
audigger
02/7/2018
12:55
Re Aivlosin the results statement includes the following encouraging words: "Substantial on-going product development covering more formulations, species and diseases is expected to substantially further increase it's revenue generating potential."
aimingupward2
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 04:45:29